
AGM/EGM3 Sept 2026, 01:58 pm
Gaudium IVF Files Annual Report for FY 2025-26
AI Summary
Gaudium IVF and Women Health Ltd has filed its Annual Report for the Financial Year 2025-26, coinciding with the notice for its 11th Annual General Meeting (AGM) scheduled for September 28, 2026. The report highlights the company's journey from a founder-led enterprise to an institution-led platform, emphasizing its growth through a hub-and-spoke model with seven hubs and 28 spokes across India. Key achievements include the integration of AI-led embryology tools and its listing on NSE and BSE on February 27, 2026. The company aims to expand access to fertility care in Tier 1 and Tier 2 cities, building on its foundation of clinical excellence and institutional capability.
Key Highlights
- Annual Report for FY 2025-26 filed, along with AGM notice.
- Company emphasizes growth via hub-and-spoke model (7 hubs, 28 spokes).
- Integrated AI-led embryology tools into clinical practice.
- Listed on NSE and BSE on February 27, 2026.
- Focus on expanding fertility care access in Tier 1 and Tier 2 cities.
Price Impact
More from GAUDIUMIVF